Editas Medicine, Inc. (EDIT)
NASDAQ: EDIT · Real-Time Price · USD
1.770
-0.010 (-0.56%)
At close: Feb 11, 2026, 4:00 PM EST
1.810
+0.040 (2.26%)
After-hours: Feb 11, 2026, 6:09 PM EST
Editas Medicine Market Cap
Editas Medicine has a market cap or net worth of $172.79 million as of February 11, 2026. Its market cap has increased by 48.44% in one year.
Market Cap
172.79M
Enterprise Value
26.79M
1-Year Change
48.44%
Ranking
Category
Stock Price
$1.77
Market Cap Chart
Since February 3, 2016, Editas Medicine's market cap has decreased from $649.70M to $172.79M, a decrease of -73.41%. That is a compound annual growth rate of -12.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 173.80M | -13.14% |
| Dec 31, 2025 | 200.10M | 90.94% |
| Dec 31, 2024 | 104.80M | -87.33% |
| Dec 29, 2023 | 827.40M | 35.66% |
| Dec 30, 2022 | 609.90M | -66.42% |
| Dec 31, 2021 | 1.82B | -58.45% |
| Dec 31, 2020 | 4.37B | 187.69% |
| Dec 31, 2019 | 1.52B | 39.66% |
| Dec 31, 2018 | 1.09B | -15.40% |
| Dec 29, 2017 | 1.29B | 122.48% |
| Dec 30, 2016 | 577.90M | -11.05% |
| Feb 3, 2016 | 649.70M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tenaya Therapeutics | 182.08M |
| Sol-Gel Technologies | 181.83M |
| Prelude Therapeutics | 177.57M |
| Sagimet Biosciences | 177.24M |
| Galectin Therapeutics | 175.37M |
| Molecular Partners AG | 174.60M |
| Tharimmune | 172.75M |
| C4 Therapeutics | 172.51M |